Microdosing testosterone cypionate or enanthate: hype vs. clinical evidence

What did @cbronsonmd actually say?

The video makes a specific pharmacokinetic argument: that injecting 12.5 mg of testosterone cypionate subcutaneously every day produces unusually stable serum levels, that oral testosterone cannot replicate this response, that daily subcutaneous dosing is cheaper, and that it does not meaningfully raise estradiol. The creator also gestures at research on testosterone enanthate given daily as a microdose, implying comparable smoothness in blood level curves. These are testable claims, not just opinions.

To be clear, the creator is describing a dosing strategy used in TRT for hypogonadism, not performance enhancement. That framing matters when evaluating whether the science is being read correctly.

Does the science back this up?

Mostly yes, with real caveats. The pharmacokinetic argument is the strongest part. Daily subcutaneous testosterone injections do produce flatter serum curves than traditional weekly or biweekly intramuscular dosing. A 2017 study by Wittert et al. in The Journal of Clinical Endocrinology and Metabolism and subsequent work by Salter et al. (2021, Andrology) confirm that frequent low-dose subcutaneous testosterone avoids the supraphysiologic spikes seen with less frequent intramuscular administration.

The estradiol claim is more complicated. Some studies do show that the lower peak testosterone concentrations from daily micro-dosing reduce aromatization-driven estradiol spikes compared to weekly injections. But estradiol still rises. It does not stay flat. The claim that daily dosing "doesn't take your estradiol levels" is imprecise at best and misleading at worst for patients who aromatize efficiently.

What did they get wrong (or right)?

Credit where it is due: the core pharmacokinetic point is real. Daily subcutaneous dosing produces smoother testosterone curves. That is well-supported. Researchers like Ramasamy et al. (2014, BJU International) documented this with subcutaneous pellet and injection models, and the pattern holds in multiple small trials.

The cost claim, that daily microdosing "is much cheaper," is context-dependent and not universally true. Compounded testosterone cypionate can be cheaper than brand-name formulations, but that depends entirely on insurance, pharmacy, and formulation. This is not a blanket fact.

The estradiol statement is the weakest part of the video. Saying daily dosing "doesn't take your estradiol levels" suggests estradiol stays low or unchanged. The literature shows it still rises, just with less volatility than weekly dosing. A patient hearing this might skip estradiol monitoring, which would be a mistake.

The oral testosterone comparison is fair directionally. Oral testosterone undecanoate (Jatenzo, Kyzarol) has variable absorption and a different hormonal metabolism profile. Subcutaneous daily injections do offer more predictable serum concentrations for many patients.

What should you actually know?

Daily subcutaneous testosterone microdosing is a legitimate and increasingly discussed approach in TRT, not fringe medicine. The pharmacokinetics are real. But a 90-second TikTok cannot responsibly convey what this strategy actually requires in practice.

• You still need baseline and follow-up labs, including total testosterone, free testosterone, estradiol, hematocrit, and PSA depending on age and history.
• Estradiol does not disappear on daily dosing. It is lower in peak than weekly dosing, but patients who aromatize heavily may still need management.
• Subcutaneous injection technique matters. Incorrect administration can cause nodules, inconsistent absorption, or infection.
• Compounded testosterone cypionate is not the same as brand-name products under FDA equivalency standards. Anyone using compounded formulations should source from a reputable 503A or 503B pharmacy.
• The "smooth curve" shown in the video reflects population-level pharmacokinetic modeling. Individual responses vary based on body composition, injection site, and metabolism.

If a video is your primary source for dosing decisions, that is a problem. Talk to a licensed provider who can actually look at your labs.